Funded Grants

A type of brain cancers called “diffuse gliomas” currently lacks effective treatments.

The increasing prevalence of anxio-depressive disorders worldwide suggests that current therapeutic strategies are insufficient in tackling this global health concern.

This research proposal investigates how a chemical modification called N6-methyladenosine (m6A) on messenger RNA influences brain health, specifically focusing on its role in sleep regulation, learning and memory, and neurodegenerative diseases such as Alzheimer’s.

Les commotions cérébrales chez les enfants sont un problème de santé publique majeur en raison de leur impact à long terme sur le développement cognitif et socio-émotionnel.

Mixed dementia is the most common form of dementia.

Multiple sclerosis (MS) is the most common cause of non-traumatic neurological disability, affecting 1 in 400 Canadian adults.

Cannabis is one of the most commonly used recreational substances in Canada, yet its effects on brain blood flow remain poorly understood.

Deregulation of brain cell metabolism is commonly observed in low-grade brain cancers.

As people live longer, our society undergoes rapid demographic change.

Glioblastoma is one of the most aggressive brain cancers, with very few treatment options and a poor survival rate.